PNAS:电惊厥疗法或可治疗抑郁症

2012-03-23 EurekAlert! EurekAlert!

3月19日,国际著名杂志PNAS在线刊登了国外研究人员的最新研究成果“Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder,”,文章中,研究者表示,电惊厥疗法可能因通过改变大脑连接进而治疗抑郁症。 一项研究报告说,电惊厥疗法(ECT)目前是治疗严重抑郁症的最有

3月19日,国际著名杂志PNAS在线刊登了国外研究人员的最新研究成果“Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder,”,文章中,研究者表示,电惊厥疗法可能因通过改变大脑连接进而治疗抑郁症。

一项研究报告说,电惊厥疗法(ECT)目前是治疗严重抑郁症的最有效的疗法,它可能因通过改变大脑的功能架构而起作用。尽管电惊厥疗法(ECT)在临床上已经取得了70多年的成功,它起作用的机制仍然不明确。Jennifer S. Perrin及其同事使用功能磁共振成像(fMRI)研究了电惊厥疗法(ECT)对9位病人的大脑功能连接的影响,这9位病人成功地接受了对严重抑郁症的治疗。

电惊厥疗法看上去下调了左前额叶背外侧区域的平均全脑连接,此前人们认为这个脑部区域参与了抑郁症而且已知能够影响认知功能。进一步的分析显示电惊厥疗法(ECT)减少了与这个区域有关的大脑功能网络的连接,同时病人的抑郁症状得到了显著改善。这组作者提出,这些发现提示增强了的连接可能是抑郁症重要方面的基础。这组作者说,对电惊厥疗法(ECT)机制的理解可以让科研人员在造成更小的创伤的情况下重复它的治疗效果。

doi:10.1073/pnas.1117206109
Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder

Jennifer S. Perrina,1, Susanne Merzb, Daniel M. Bennetta, James Curriea, Douglas J. Steelec, Ian C. Reida, and Christian Schwarzbauerb

To date, electroconvulsive therapy (ECT) is the most potent treatment in severe depression. Although ECT has been successfully applied in clinical practice for over 70 years, the underlying mechanisms of action remain unclear. We used functional MRI and a unique data-driven analysis approach to examine functional connectivity in the brain before and after ECT treatment. Our results show that ECT has lasting effects on the functional architecture of the brain. A comparison of pre- and posttreatment functional connectivity data in a group of nine patients revealed a significant cluster of voxels in and around the left dorsolateral prefrontal cortical region (Brodmann areas 44, 45, and 46), where the average global functional connectivity was considerably decreased after ECT treatment (P < 0.05, family-wise error-corrected). This decrease in functional connectivity was accompanied by a significant improvement (P < 0.001) in depressive symptoms; the patients’ mean scores on the Montgomery Asberg Depression Rating Scale pre- and posttreatment were 36.4 (SD = 4.9) and 10.7 (SD = 9.6), respectively. The findings reported here add weight to the emerging “hyperconnectivity hypothesis” in depression and support the proposal that increased connectivity may constitute both a biomarker for mood disorder and a potential therapeutic target.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1855242, encodeId=30301855242cf, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sat Sep 08 05:35:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023860, encodeId=dd002023860da, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Wed Sep 19 05:35:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998835, encodeId=f5c219988352e, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Jul 05 16:35:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425870, encodeId=c0cb14258e0fe, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Mar 25 12:35:00 CST 2012, time=2012-03-25, status=1, ipAttribution=)]
    2012-09-08 drwjr
  2. [GetPortalCommentsPageByObjectIdResponse(id=1855242, encodeId=30301855242cf, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sat Sep 08 05:35:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023860, encodeId=dd002023860da, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Wed Sep 19 05:35:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998835, encodeId=f5c219988352e, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Jul 05 16:35:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425870, encodeId=c0cb14258e0fe, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Mar 25 12:35:00 CST 2012, time=2012-03-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1855242, encodeId=30301855242cf, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sat Sep 08 05:35:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023860, encodeId=dd002023860da, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Wed Sep 19 05:35:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998835, encodeId=f5c219988352e, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Jul 05 16:35:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425870, encodeId=c0cb14258e0fe, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Mar 25 12:35:00 CST 2012, time=2012-03-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1855242, encodeId=30301855242cf, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sat Sep 08 05:35:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023860, encodeId=dd002023860da, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Wed Sep 19 05:35:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998835, encodeId=f5c219988352e, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Jul 05 16:35:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425870, encodeId=c0cb14258e0fe, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Mar 25 12:35:00 CST 2012, time=2012-03-25, status=1, ipAttribution=)]
    2012-03-25 zz12341235

相关资讯

EPCRC发布首部癌症姑息治疗抑郁症管理指南

  癌症患者在姑息治疗中发生抑郁很常见,为使临床医师有“据”可依地进行处理,欧洲姑息治疗研究协作组(EPCRC)在系统性回顾了现有循证医学证据并进行了德尔斐(Delphi)研究后,制定出欧洲第一部癌症姑息治疗抑郁症管理指南。相关内容参见《欧洲癌症杂志》 [Eur J Cancer 2011, 47(5): 702]。   姑息治疗中抑郁症的预

PLoS One:HDAC6与抑郁症相关

近日,日本研究人员发现脑部神经细胞内含量很高的一种蛋白质与抑郁症有关。如果阻碍这种蛋白质发挥作用,能获得与使用抗抑郁药物相同的效果。相关报告已刊登在美国科学杂志《科学公共图书馆—综合》PLoS One的网络版上。日本爱知县身心障碍者精神发育障碍研究所与名古屋市立大学研究人员发现,在大脑发育时,一种名为HDAC6的蛋白质会增多。而在产生血清素的神经细胞中,也含有很多这种蛋白质。血清素对调节不安等情绪

双语医学阅读:抑郁症疗法或改变

  New Depression Findings Could Alter Treatments   新的研究结果可能改变抑郁症的治疗方法   The results of two new studies may signal a substantial shift in the way psychiatrists and researchers think about treatment f

甲状旁腺切除术可改善抑郁症及心血管异常

原发性甲状旁腺机能亢进(PHP)患者伴有抑郁症或亚临床心血管异常正在成为新的甲状旁腺切除术适应证。PHP已不再局限于一种具有代谢性骨病、胃肠道功能紊乱和肾结石等典型临床表现的疾病,在常规进行血清钙测定的时代,多数患者并无症状,或报告情绪、认知和神经肌肉功能异常等非特异性症状。美国骨与矿物质研究协会年会上报告的研究提示,在PHP患者中,有临床意义的抑郁症患病率更高且更严重,并且亚临床心血管异常也更为

AFM:有伴随疾病的抑郁症患者亦可接受抗抑郁症治疗

德州大学西南医学中心的David W. Morris 博士等近日在《家庭医学年报》(Annals of Family Medicine)发表论文称,对有其他伴随疾病的重度抑郁症患者使用抗抑郁症治疗也是安全且有效的。作者通过二次分析发现,与没有伴随疾病的抑郁症患者相比,患有高血压、糖尿病、关节炎等3至4种伴随疾病的抑郁症患者的28周缓解率没有明显差别。 之前有研究称,伴随疾病会干扰抑郁症的治疗,患